RANTES Polyclonal Antibody, Biotin Conjugated, Rabbit

Catalog Number: BSS-BS-1324R-BIOTIN
Article Name: RANTES Polyclonal Antibody, Biotin Conjugated, Rabbit
Biozol Catalog Number: BSS-BS-1324R-BIOTIN
Supplier Catalog Number: bs-1324R-Biotin
Alternative Catalog Number: BSS-BS-1324R-BIOTIN-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: ELISA, IHC-Fr, IHC-P
Species Reactivity: Human, Mouse, Porcine
Conjugation: Biotin
Alternative Names: SISd, eoCP, SCYA5, RANTES, TCP228, D17S136E, SIS-delta, C-C motif chemokine 5, Eosinophil chemotactic cytokine, Small-inducible cytokine A5, T cell-specific protein P228, T-cell-specific protein RANTES, CCL5
Chemoattractant for blood monocytes, memory T-helper cells and eosinophils. Causes the release of histamine from basophils and activates eosinophils. May activate several chemokine receptors including CCR1, CCR3, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant RANTES protein induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form RANTES(3-68) acts as a natural chemotaxis inhibitor and is a more potent inhibitor of HIV-1-infection. The second processed form RANTES(4-68) exhibits reduced chemotactic and HIV-suppressive activity compared with RANTES(1-68) and RANTES(3-68) and is generated by an unidentified enzyme associated with monocytes and neutrophils (PubMed:1679162, PubMed:13864, PubMed:8525373, PubMed:9516414, PubMed:15923218). May also be an agonist of the G protein-coupled receptor GPR75, stimulating inositol trisphosphate production and calcium mobilization through its activation. Together with GPR75, may play a role in neuron survival through activation of a downstream signaling pathway involving the PI3, Akt and MAP kinases. By activating GPR75 may also play a role in insulin secretion by islet cells (PubMed:23979485).
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 6352
Pubmed: 28411140
UniProt: P13501
Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human CCL5
Target: RANTES
Application Dilute: ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500)